Literature DB >> 18923836

Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology.

Yasushi Nishihira1, Chun-Feng Tan, Yasuhiro Hoshi, Keisuke Iwanaga, Megumi Yamada, Izumi Kawachi, Mitsuhiro Tsujihata, Isao Hozumi, Takashi Morita, Osamu Onodera, Masatoyo Nishizawa, Akiyoshi Kakita, Hitoshi Takahashi.   

Abstract

Recently, sporadic amyotrophic lateral sclerosis (SALS), a fatal neurological disease, has been shown to be a multisystem proteinopathy of TDP-43 in which both neurons and glial cells in the central nervous system are widely affected. In general, the natural history of SALS is short (<5 years). However, it is also known that a few patients may survive for 10 years or more, even without artificial respiratory support (ARS). In the present study using TDP-43 immunohistochemistry, we examined various regions of the nervous system in six patients with SALS of long duration (10-20 years) without ARS, in whom lower motor-predominant disease with Bunina bodies and ubiquitinated inclusions (UIs) in the affected lower motor neurons was confirmed. One case also showed UIs in the hippocampal dentate granule cells (UDG). In all cases, except one with UDG, the occurrence of TDP-43-immunoreactive (ir) neuronal cytoplasmic inclusions (NCIs) was confined to a few regions in the spinal cord and brainstem, including the anterior horns. In one case with UDG, TDP-43-ir NCIs were also detected in the substantia nigra, and some regions of the cerebrum, including the hippocampal dentate gyrus (granule cells). The number of neurons displaying NCIs in each region was very small (1-3 per region, except the dentate gyrus). On the other hand, the occurrence of TDP-43-ir glial cytoplasmic inclusions (GCIs) was more widespread in the central nervous system, including the cerebral white matter. Again, however, the number of glial cells displaying GCIs in each region was very small (1-3 per region). In conclusion, compared to the usual form of SALS, TDP-43 pathology shown in SALS of long duration was apparently mild in degree and limited in distribution, corresponding to the relatively benign clinical courses observed. It is now apparent that SALS of long duration is actually part of a TDP-43 proteinopathy spectrum.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18923836     DOI: 10.1007/s00401-008-0443-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

Review 1.  Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration.

Authors:  Edward B Lee; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2011-11-30       Impact factor: 34.870

2.  Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy.

Authors:  Felix Geser; Beth Stein; Michael Partain; Lauren B Elman; Leo F McCluskey; Sharon X Xie; Vivianna M Van Deerlin; Linda K Kwong; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2011-01-12       Impact factor: 17.088

Review 3.  On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.

Authors:  F Geser; D Prvulovic; L O'Dwyer; O Hardiman; P Bede; A L W Bokde; J Q Trojanowski; H Hampel
Journal:  Prog Neurobiol       Date:  2011-09-03       Impact factor: 11.685

4.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

5.  Molecular dissection of TDP-43 proteinopathies.

Authors:  Masato Hasegawa; Takashi Nonaka; Hiroshi Tsuji; Akira Tamaoka; Makiko Yamashita; Fuyuki Kametani; Mari Yoshida; Tetsuaki Arai; Haruhiko Akiyama
Journal:  J Mol Neurosci       Date:  2011-06-16       Impact factor: 3.444

6.  Ophthalmic Manifestations of Amyotrophic Lateral Sclerosis (An American Ophthalmological Society Thesis).

Authors:  Nicholas J Volpe; Joseph Simonett; Amani A Fawzi; Teepu Siddique
Journal:  Trans Am Ophthalmol Soc       Date:  2015

7.  Amyotrophic lateral sclerosis phenotypes significantly differ in terms of magnetic susceptibility properties of the precentral cortex.

Authors:  Giorgio Conte; Valeria Elisa Contarino; Silvia Casale; Claudia Morelli; Sara Sbaraini; Elisa Scola; Francesca Trogu; Silvia Siggillino; Claudia Maria Cinnante; Luca Caschera; Francesco Maria Lo Russo; Fabio Maria Triulzi; Vincenzo Silani
Journal:  Eur Radiol       Date:  2021-01-05       Impact factor: 5.315

Review 8.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

9.  Transgenic rat model of neurodegeneration caused by mutation in the TDP gene.

Authors:  Hongxia Zhou; Cao Huang; Han Chen; Dian Wang; Carlisle P Landel; Pedro Yuxing Xia; Robert Bowser; Yong-Jian Liu; Xu Gang Xia
Journal:  PLoS Genet       Date:  2010-03-26       Impact factor: 5.917

Review 10.  Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.

Authors:  Felix Geser; Maria Martinez-Lage; Linda K Kwong; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.